S. Pérez-Recio

The Impact of Culturing the Organ Preservation Fluid on Solid Organ Transplantation: A Prospective Multicenter Cohort Study

G. Blanco-Fernández, C. Jiménez-Romero, D. Paredes, 2019, Open forum infectious diseases.

Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial)

L. Anibarro, P. Gijón, R. Luque, 2022, PloS one.

Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study

C. Tebé, A. Barać, F. Alcaide, 2021, Microbiology spectrum.

Ceftolozane/tazobactam for difficult‐to‐treat Gram‐negative infections: A real‐world tertiary hospital experience

J. Carratalá, A. Padullés, G. Cuervo, 2022, Journal of clinical pharmacy and therapeutics.

Impact of the COVID-19 pandemic on tuberculosis management in Spain

I. Molina, J. Llenas-García, A. Sánchez-Montalvá, 2021, International Journal of Infectious Diseases.

Tuberculosis prevention in patients undergoing kidney transplantation: A nurse‐led program for screening and treatment

J. Cruzado, L. Muñoz, M. Santin, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

D. Podzamczer, J. Blanco, M. Laguno, 2020, Clinical Microbiology and Infection.

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

A. Borobia, D. Podzamczer, Á. Soriano, 2021, The Lancet. Infectious diseases.

Rifabutin for treating tuberculosis in solid organ transplant recipients: A retrospective observational study and literature review

L. Lladó, A. Gomila-Grange, M. Santin, 2020, Transplant infectious disease : an official journal of the Transplantation Society.